Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Poor adherence to treatment associated with a high recurrence in a bipolar disorder outpatient sample.

Gutiérrez-Rojas L, Jurado D, Martínez-Ortega JM, Gurpegui M.

J Affect Disord. 2010 Dec;127(1-3):77-83. doi: 10.1016/j.jad.2010.05.021.

PMID:
20576292
2.

The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.

Lee JH, Dunner DL.

Depress Anxiety. 2008;25(2):91-7.

PMID:
17311265
3.

Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study.

Perlis RH, Ostacher MJ, Miklowitz DJ, Hay A, Nierenberg AA, Thase ME, Sachs GS.

J Clin Psychiatry. 2010 Mar;71(3):296-303. doi: 10.4088/JCP.09m05514yel.

PMID:
20331931
4.

Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.

Simon NM, Otto MW, Weiss RD, Bauer MS, Miyahara S, Wisniewski SR, Thase ME, Kogan J, Frank E, Nierenberg AA, Calabrese JR, Sachs GS, Pollack MH; STEP-BD Investigators..

J Clin Psychopharmacol. 2004 Oct;24(5):512-20.

PMID:
15349007
5.

Different profile of substance abuse in relation to predominant polarity in bipolar disorder: The Vitoria long-term follow-up study.

González-Pinto A, Alberich S, Barbeito S, Alonso M, Vieta E, Martínez-Arán A, Saenz M, López P.

J Affect Disord. 2010 Aug;124(3):250-5. doi: 10.1016/j.jad.2009.11.005.

PMID:
19959240
6.

[Treatment of a first manic episode].

Maurel M, Kaladjian A, Fakra E, Besnier N, Adida M, Azorin JM.

Encephale. 2010 Jan;36 Suppl 1:S23-6. doi: 10.1016/S0013-7006(10)70006-3. Review. French.

PMID:
20141804
7.

[Screening and management of bipolar disorders: results].

Llorca PM, Courtet P, Martin P, Abbar M, Gay C, Meynard JA, Baylé F, Hamon M, Lançon C, Thibaut F, Thomas P, Lancrenon S, Guillaume S, Samalin L; l’Association Française de Psychiatrie Biologique et Neuropsychopharmacologique (AFPBN)..

Encephale. 2010 Mar;36 Suppl 4:S86-102. doi: 10.1016/S0013-7006(10)70037-3. French. No abstract available.

PMID:
21185427
8.

Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.

Mazza M, Mandelli L, Di Nicola M, Harnic D, Catalano V, Tedeschi D, Martinotti G, Colombo R, Bria P, Serretti A, Janiri L.

J Affect Disord. 2009 May;115(1-2):27-35. doi: 10.1016/j.jad.2008.08.019.

PMID:
18845344
9.

Despite clinical differences, bipolar disorder patients from acute wards and outpatient clinics have similar educational and disability levels compared to the general population.

Schoeyen HK, Vaaler AE, Auestad BH, Malt UF, Melle I, Andreassen OA, Morken G.

J Affect Disord. 2011 Jul;132(1-2):209-15. doi: 10.1016/j.jad.2011.02.025.

PMID:
21440307
10.

Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder.

Bauer MS, Altshuler L, Evans DR, Beresford T, Williford WO, Hauger R; VA Cooperative Study #430 Team..

J Affect Disord. 2005 Apr;85(3):301-15.

PMID:
15780700
11.

Assessment of medication adherence in a cohort of patients with bipolar disorder.

González-Pinto A, Reed C, Novick D, Bertsch J, Haro JM.

Pharmacopsychiatry. 2010 Nov;43(7):263-70. doi: 10.1055/s-0030-1263169.

PMID:
20842617
12.
13.

The impact of treatment-resistant depression on health care utilization and costs.

Crown WH, Finkelstein S, Berndt ER, Ling D, Poret AW, Rush AJ, Russell JM.

J Clin Psychiatry. 2002 Nov;63(11):963-71.

PMID:
12444808
14.

The prevalence of mixed episodes during the course of illness in bipolar disorder.

Kessing LV.

Acta Psychiatr Scand. 2008 Mar;117(3):216-24. doi: 10.1111/j.1600-0447.2007.01131.x.

PMID:
18241307
15.

The effect of alcohol and substance abuse on the course of bipolar affective disorder.

Feinman JA, Dunner DL.

J Affect Disord. 1996 Feb 12;37(1):43-9.

PMID:
8682977
16.

[Screening and management of bipolar disorders: methodology].

Llorca PM, Courtet P, Martin P, Abbar M, Gay C, Meynard JA, Baylé F, Hamon M, Lançon C, Thibaut F, Thomas P, Lancrenon S, Guillaume S, Samalin L.

Encephale. 2010 Mar;36 Suppl 4:S79-85. doi: 10.1016/S0013-7006(10)70036-1. French. No abstract available.

PMID:
21185426
17.

[Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].

Verdoux H, Mury M, Besançon G, Bourgeois M.

Encephale. 1996 Mar-Apr;22(2):95-101. French.

PMID:
8706627
18.

Differences in the ICD-10 diagnostic subtype of depression in bipolar disorder compared to recurrent depressive disorder.

Kessing LV, Jensen HM, Christensen EM.

Psychopathology. 2008;41(3):141-6. doi: 10.1159/000113006.

PMID:
18187963
19.

Outcome in the pharmacologic treatment of bipolar disorder.

Keck PE Jr, McElroy SL.

J Clin Psychopharmacol. 1996 Apr;16(2 Suppl 1):15S-23S. Review.

PMID:
8707996
20.

Bipolar disorder preceded by substance abuse: a different phenotype with not so poor outcome?

Pacchiarotti I, Di Marzo S, Colom F, Sánchez-Moreno J, Vieta E.

World J Biol Psychiatry. 2009;10(3):209-16.

PMID:
17886170
Items per page

Supplemental Content

Support Center